FTS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of FTS Antibodies for advanced research in cellular signaling and regulation. FTS Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FTS, or farnesylthiosalicylic acid, plays a key role in modulating protein interactions and cellular processes, particularly in oncogenic signaling pathways. By inhibiting farnesylation, FTS influences cell proliferation and survival, making it an important target for cancer research. Understanding FTS mechanisms provides valuable insights into therapeutic strategies for various malignancies. Researchers worldwide rely on FTS research to advance understanding of cellular pathways and disease mechanisms. Current studies focus on how FTS impacts different types of cancer and cellular responses. Ongoing research continues to reveal new functions and applications of FTS in cellular biology. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to cancer research and therapeutic development.